Skip to main content
Caplight Logo









Arctoris

Arctoris

Private
AbingdonHealthcare & Life Scienceshttps://www.arctoris.com/

Last Round

Grant

May 1, 2020

Total Funding Raised

$4.03M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Arctoris is a biotechnology research company that operates an automated drug discovery platform using robotics and artificial intelligence to accelerate the development of new drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Industrial Robotics, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

automated drug discoverylab automationcloud labrobotic labcontract research organizationCROdrug discovery servicesexperiments-as-a-servicelab as a serviceAI-ready datapartnership research organisationPROrobotics platformreproducible databiologics discoverybiochemistry servicescell biology services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arctoris Comparables

Compare Arctoris with similar companies based on industry and business-model similarity.

Arctoris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strateos
86%
ChemLex
81%
Emerald Therapeutics
80%

Arctoris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2020
SeedSep 30, 2019

Key People

Founding team and executive leadership

Paul Custance

Chief Financial Officer, Financial Director

Executive Team

DPhil Poppy Roworth

Chief Operating Officer

Executive Team

Arctoris Investors

Notable investors and investment history

Arctoris investors
InvestorRounds
TanarraSeed
Innovate UKGrant
TD VeenSeed
Formic VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 43% MoM.

  • Jul 22, 2025

    Grew 20% QoQ, from 35 to 42 employees.

Arctoris Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arctoris Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arctoris's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon
Employee Range39
Year Founded2016
Last FundingMay 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?